News Release

New 3D imaging method offers promise of better IVF outcomes

Innovative research has introduced a novel 3D imaging model designed to identify features of blastocysts – the early stage of development for an implanted embryo – associated with successful pregnancies

Reports and Proceedings

European Society of Human Reproduction and Embryology

Innovative research, presented today at the ESHRE 40th Annual Meeting in Amsterdam, has introduced a novel 3D imaging model designed to identify features of blastocysts – the early stage of development for an implanted embryo – associated with successful pregnancies. This new approach could transform current blastocyst selection methods, and open avenues for increased pregnancy rates [1].

The shape and structure of blastocysts can predict the success of a pregnancy, aiding blastocyst selection for in vitro fertilisation (IVF). However, selecting the right embryo or blastocyst remains a significant challenge within IVF [2].

“Traditionally, the quality of blastocysts is assessed using 2D methods that lack depth and comprehensive indicators,” says Dr Bo Huang, lead author of the study. “Although some 3D methods exist, they aren’t practical or safe for clinical use. This study bridges that gap by introducing a clinically applicable 3D evaluation method and reveals previously unrecognised spatial features of blastocysts indicative of outcomes.”

The study included women under 40 years old with a uterine lining (endometrial thickness) of 7-16mm and no more than one previous embryo transfer failure. Using a device called EmbryoScope+, researchers took detailed images of 2,141 frozen-thaw single blastocysts.

Advanced technology was used to create 3D models of these blastocysts, capturing detailed information about their outer layer (trophectoderm) and inner cell mass. These models were further analysed to find new blastocyst features and determine how these features relate to successful pregnancies.

The study tested the model by comparing it with fluorescence imaging of human blastocysts and achieved over 90% accuracy. Key measurements identified capture the blastocyst’s size, shape and cell characteristics.

Parameters related to size, such as overall volume, cavity volume, and surface area were found to be linked to higher pregnancy rates, and specific features of the inner cell mass and outer layer were also strongly associated with better pregnancy outcomes.

Dr Huang comments, “These results match what we see in clinical outcomes, but we couldn’t previously measure these. This study shows that the 3D shape of the blastocyst’s inner cell mass, it’s position, and how the surrounding cells are arranged can be important indicators of success, which we didn’t know before.”

Moving forward, the research team plans to collaborate with multiple centres to further validate these findings and invites reproductive centres worldwide to join these efforts. The ultimate goal is to make the 3D evaluation of blastocysts a standard part of clinical practice, bringing new hope to people undergoing IVF.  

Professor Dr Anis Feki, Chair-Elect of ESHRE, states, “While the new 3D imaging model for blastocyst evaluation shows great promise in improving embryo selection for IVF, it is essential to validate these findings through further studies and collaborations. This method could potentially enhance IVF outcomes, but its clinical application should be approached with careful consideration.”

The study abstract will be published today in Human Reproduction, one of the world’s leading reproductive medicine journals.




Notes to editors:

A reference to the ESHRE Annual Meeting must be included in all coverage and/or articles associated with this study.

For more information or to arrange an expert interview, please contact the ESHRE Press Office at:


Video supplement:

A supplementary video demonstrating the method used in this study is available for viewing here.


About the study author:

Dr Bo Huang is an embryologist at the Reproductive Medicine Center of Tongji Hospital, Tongji Medicine College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China.


About the European Society of Human Reproduction and Embryology

The main aim of ESHRE is to promote interest in infertility care and to aim for a holistic understanding of reproductive biology and medicine.

ESHRE collaborates world-wide and advocates universal improvements in scientific research, encourages and evaluates new developments in the field, and fosters harmonisation in clinical practice. It also provides guidance to enhance effectiveness, safety and quality assurance in clinical and laboratory procedures, psychosocial care, and promotes ethical practice. ESHRE also fosters prevention of infertility and related educational programmes and promotes reproductive rights regardless of the individual’s background. ESHRE’s activities include teaching, training, professional accreditations, mentoring and career planning for junior professionals, as well as developing and maintaining data registries. It also facilitates and disseminates research in human reproduction and embryology to the general public, scientists, clinicians, allied personnel, and patient associations.



About Human Reproduction

Human Reproduction is a monthly journal of ESHRE and is one of the top three journals in the world in the field of reproductive biology, obstetrics and gynaecology. It is published by Oxford Journals, a division of Oxford University Press.



  1. Huang, B. et al. (2024). The spatial conformational features of blastocysts can serve as a new basis for selection. Human Reproduction. Available at:
  2. Günther, V., Dasari-Mettler, A., Mettler, L., Otte, S. V., Ackermann, J., Maass, N., & Alkatout, I. (2022). Is Blastocyst Culture Responsible for Higher Pregnancy Rates? A Critical Analysis of the Day of Optimal Embryo Transfer and Embryo Quality. JBRA Assisted Reproduction, 26(3), 492–499.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.